ATELLICA TM CH GLICOPROTEÍNA ÁCIDA Α-1 (AAG) - COFEPRIS Registration 1519R2018 SSA
Access comprehensive regulatory information for ATELLICA TM CH GLICOPROTEÍNA ÁCIDA Α-1 (AAG) (ATELLICA TM CH Α-1 ACID GLYCOPROTEIN (AAG)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1519R2018 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on June 13, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ATELLICA TM CH GLICOPROTEÍNA ÁCIDA Α-1 (AAG) ES PARA USO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUANTITATIVA DE GLICOPROTEÍNA ÁCIDA Α-1 EN SUERO Y PLASMA (HEPARINA DE LITIO, EDTA POTÁSICO) HUMANOS. LAS MEDICIONES DE GLICOPROTEÍNA ÁCI
THE ATELLICA TM CH Α-1 ACID GLYCOPROTEIN (AAG) ASSAY IS FOR IN VITRO DIAGNOSTIC USE IN THE QUANTITATIVE DETERMINATION OF Α-1 ACID GLYCOPROTEIN IN HUMAN SERUM AND PLASMA (LITHIUM HEPARIN, POTASSIUM EDTA). ACID GLYCOPROTEIN MEASUREMENTS